N-Gene is a clinical-stage bio-pharmaceutical drugs designed to focus on the development of proprietary synthetic small molecules.
Business Model:
Revenue: $16.3M
Employees: 11-50
Address: 575 Madison Ave
City: New York
State: NY
Zip: 10022
Country: US
N-Gene is a developer of clinical-stage bio-pharmaceutical drugs designed to focus on the discovery, development, and commercialization of proprietary synthetic small molecules. The company&s;s drugs use proprietary synthetic small molecule BGP-15 that has been found efficacious in various indications relating to adverse metabolic conditions, including type 2 diabetes mellitus by blocking JNK phosphorylation and has a new therapeutic effect via stress response modulation, enabling pharmaceutical companies to get a series of synthetic molecules to treat the insulin-resistance syndrome, improve cancer chemotherapy, and slow skin aging.
Contact Phone:
+12126050225
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 4/2002 | Corporate Round | 1 | - |
Allos Therapeutics Allos Therapeutics |
4/2006 | Series B | 1 | $3M |
Hiventures Hiventures |
2/2009 | Private Equity Round | 1 | - |
Bankár Bankár |
2/2009 | Private Equity Round | 1 | - |
Bankár Bankár |
4/2002 | Corporate Round | 1 | - |
Allos Therapeutics Allos Therapeutics |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|